SEQUENT.NS

Sequent Scientific Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$23.20B

PE Ratio

208.11198917351376

EV to Ebitda

—

Earnings Yield

39752637.23%

Revenue (TTM)

$171.7M

Net Income (TTM)

$1.0M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

-3.70%

Profit Margin

0.52%

Return on Equity

—

Debt to Equity Ratio

0.5171189786643238

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$23.20B

Revenue TTM$171.7M

Shares Outstanding249.4M

Float117730852

Insider Ownership54.84%

Institutional Ownership7.18%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)-3.70%

Rev Growth Est 1Y Forward0.1600

EPS Growth (Quarterly YoY)-44.80%

EPS Growth Est Quarterly0

LT EPS Growth Estimates94.20%

Operations15 fields›

Revenue TTM$171.7M

Gross Margin TTM42.09%

Gross Margin (Quarterly)41.39%

Operating Margin TTM2.07%

Operating Margin (Quarterly)-2.12%

Profit Margin TTM0.52%

Profit Margin (Quarterly)-1.11%

Net Income TTM$1.0M

EPS TTM0.29

EBIT Margin TTM5.02%

EBITDA TTM$8.6M

CFO % of Revenue (Quarterly)-14.07%

Capex % of Revenue TTM5.18%

Capital Expenditures$8.9M

FCF % of Revenue (Quarterly)-0.13%

Efficiency1 fields›

ROA1.25%

Valuation7 fields›

P/E (TTM)208.11198917351376

P/E Forward33.3333

EV/Revenues (TTM)1.8885

Price To Book2.335229928519519

Earnings Yield39752637.23%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity7 fields›

Cash Per Share2.495698489509967

Current Ratio1.5361623522565957

Goodwill & Intangibles$2980.56T

Total Assets$14934.19T

Shareholders Equity$7375.44T

Debt to Equity0.5171189786643238

Interest Expense$244.1M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield39752637.23%